Gene · 4171
Papers3,775
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,775
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Symmetric inheritance of parental histones contributes to safeguarding the fate of mouse embryonic stem cells during differentiation. | Nat Genet | 2023 | 37666989 | PubTator, text mining | PubMed |
| Clinical, morphologic and molecular heterogeneity of HPV-associated oropharyngeal cancer. | Oncogene | 2023 | 37666939 | PubTator, text mining | PubMed |
| Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK Inhibitor. | Cancer Res Commun | 2023 | 37663435 | PubTator, text mining | PubMed |
| Retraction Note: NF-κB maintains the stemness of colon cancer cells by downregulating miR-195- 5p/497-5p and upregulating MCM2. | J Exp Clin Cancer Res | 2023 | 37658445 | PubTator, text mining | PubMed |
| Identification of HOXB9 based on comprehensive bioinformatics analysis for predicting prognosis of head and neck squamous cell carcinoma. | Medicine (Baltimore) | 2023 | 37657018 | PubTator, text mining | PubMed |
| DONSON facilitates Cdc45 and GINS chromatin association and is essential for DNA replication initiation. | Nucleic Acids Res | 2023 | 37638758 | PubTator, text mining | PubMed |
| Whole Exome Sequencing of Thymoma Patients Exhibiting Exceptional Responses to Pemetrexed Monotherapy. | Cancers (Basel) | 2023 | 37627046 | PubTator, text mining | PubMed |
| Coming of Age: Targeting Cyclin K in Cancers. | Cells | 2023 | 37626854 | PubTator, text mining | PubMed |
| Cyclin Dependent Kinase Inhibitor 2A Genetic and Epigenetic Alterations Interfere with Several Immune Components and Predict Poor Clinical Outcome. | Biomedicines | 2023 | 37626750 | PubTator, text mining | PubMed |
| Chromosomal instability and a deregulated cell cycle are intrinsic features of high-risk gastrointestinal stromal tumours with a metastatic potential. | Mol Oncol | 2023 | 37622176 | PubTator, text mining | PubMed |
| Desmocollin-1 is associated with pro-metastatic phenotype of luminal A breast cancer cells and is modulated by parthenolide. | Cell Mol Biol Lett | 2023 | 37620794 | PubTator, text mining | PubMed |
| RNAPII-dependent ATM signaling at collisions with replication forks. | Nat Commun | 2023 | 37620345 | PubTator, text mining | PubMed |
| Trim33 masks a non-transcriptional function of E2f4 in replication fork progression. | Nat Commun | 2023 | 37612308 | PubTator, text mining | PubMed |
| Identification of Selective ATP-Competitive CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome Function. | Res Sq | 2023 | 37609279 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveals molecular pathway network alterations in human early-stage primary hepatic carcinomas: potential for 3P medical approach. | EPMA J | 2023 | 37605650 | PubTator, text mining | PubMed |
| NFIB facilitates replication licensing by acting as a genome organizer. | Nat Commun | 2023 | 37604829 | PubTator, text mining | PubMed |
| Wnt3a signaling with serum supply induces replication stress in cultured cells. | Biochem Biophys Rep | 2023 | 37601449 | PubTator, text mining | PubMed |
| Center for Interdisciplinary Research in Health (CIIS) National Meeting 2023. | BMC Proc | 2023 | 37599356 | PubTator, text mining | PubMed |
| Early diagnostic and prognostic biomarkers for gastric cancer: systems-level molecular basis of subsequent alterations in gastric mucosa from chronic atrophic gastritis to gastric cancer. | J Genet Eng Biotechnol | 2023 | 37594635 | PubTator, text mining | PubMed |
| Primary microcephaly gene CENPE is a novel biomarker and potential therapeutic target for non-WNT/non-SHH medulloblastoma. | Front Immunol | 2023 | 37593739 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4171/papers?page=14